Acute pathophysiological effects of intratracheal instillation of budesonide and exogenous surfactant in a neonatal surfactant-depleted piglet model

Pediatrics and Neonatology

Volumn 51, Issue 4, 2010, Pages 219-226

  Yang, Chia Feng ^a,b   Jeng, Mei Jy ^a,b   Soong, Wen Jue ^a,b   Lee, Yu Sheng ^a,b   Tsao, Pen Chen ^a,b   Tang, Ren Bin ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Budesonide; Corticosteroid; Piglet; Respiratory distress syndrome; Surfactant

Indexed keywords

BUDESONIDE; GLUCOCORTICOID; LUNG SURFACTANT;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG INSTILLATION; HUMAN; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; SWINE; TRACHEA;

ANIMALS; ANIMALS, NEWBORN; BUDESONIDE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INSTILLATION, DRUG; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SWINE; TRACHEA;

EID: 79952113804     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-9572(10)60042-3     Document Type: Article

References (44)

1. Cools F, Henderson-Smart DJ, Offringa M, Askie LM. Elective high-frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 2009;3:CD000104.
2. Engle WA; American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008;121:419-32. (Pubitemid 351198470)
3. Crowley P. WITHDRAWN: Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2007;3: CD000065.
4. Shah V, Ohlsson A, Halliday HL, Dunn MS. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev 2007;4:CD001969.
5. Sweet D, Bevilacqua G, Carnielli V, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med 2007;35:175-86. (Pubitemid 46700981)
6. Stevens TP, Blennow M, Myers EH, Soll R. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007;4:CD003063.
7. Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2007;3:CD003935.
8. Teksam O, Kale G. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome. Pathol Res Pract 2009;205:35-41.
9. Yeh TF, Lin HC, Chang CH, et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 2008;121:e1310-8.
10. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 1991;88:421-7.
11. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 1990;117:273-82. (Pubitemid 20238546)
12. Halliday HL, Ehrenkranz RA. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2000;2:CD001146.
13. Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics 2001;1083:741-8.
14. Buimer M, van Wassenaer AG, Kok JH. Postnatal administration of dexamethasone for weaning off the ventilator affects thyroid function. Neonatology 2008;94:164-9.
15. Shah SS, Ohlsson A, Halliday H, Shah VS. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very-low-birth-weight preterm infants. Cochrane Database Syst Rev 2007;4:CD002057.
16. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998;101:E7.
17. Gross SJ, Anbar RD, Mettelman BB. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics 2005;115:681-7. (Pubitemid 43373029)
18. Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177-81.
19. Jeng MJ, Soong WJ, Lee YS. Effective lavage volume of diluted surfactant improves the outcome of meconium aspiration syndrome in newborn piglets. Pediatr Res 2009;66:107-12.
20. Jeng MJ, Lee YS, Soong WJ. Effects of perfluorochemicals for intrapulmonary vancomycin administration and partial liquid ventilation in an animal model of meconium-injured lungs. Acta Paediatr Taiwan 2007;48:309-16.
21. Jeng MJ, Soong WJ, Lee YS, et al. Effects of therapeutic broncho-alveolar lavage and partial liquid ventilation on meconium-aspirated newborn piglets. Critical Care Medicine 2006;34:1099-105.
22. Lachmann B, Roberston B, Petro W, et al. Experimental respiratory distress induced by removal of alveolar surfactant with bronchial lavage. Bull Eur Physiopath Respir 1976;12:186-7.
23. Jeng MJ, Kou YR, Sheu CC, Hwang B. Effects of partial liquid ventilation with FC-77 on acute lung injury in newborn piglets. Pediatr Pulmonol 2002;33:12-21. (Pubitemid 34031549)
24. Jeng MJ, Yang SS, Wolfson MR, Shaffer TH. Perfluorochemical (PFC) combinations for acute lung injury: an in vitro and in vivo study in juvenile rabbits. Pediatr Res 2003;53:81-8. (Pubitemid 36033986)
25. Rotta AT, Steinhorn DM. Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. Crit Care Med 1998;26:1707-15.
26. Jeng MJ, Kou YR, Sheu CC, Hwang B. Effects of exogenous surfactant supplementation and partial liquid ventilation on acute lung injury induced by wood smoke inhalation in newborn piglets. Crit Care Med 2003;31:1166-74. (Pubitemid 36444430)
27. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;1:CD001144.
28. Halliday HL, Ehrenkranz RA, Doyle LW. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009;1:CD001145.
29. Halliday HL, Ehrenkranz RA, Doyle LW. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009; 1:CD001146.
30. Romagnoli C, Zecca E, Luciano R, Torrioli G, Tortorolo G. A three year follow-up of preterm infants after moderately early treatment with dexamethasone. Arch Dis Child Fetal Neonatal Ed 2002;87:F55-8. (Pubitemid 34753801)
31. O'Callaghan C, Hardy J, Stammers J, Stephenson TJ, Hull D. Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Arch Dis Child 1992;67:20-4.
32. Fajardo C, Levin D, Garcia M, Adrams D, Adamson I. Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits. Pediatr Res 1998;43:542-7. (Pubitemid 28157966)
33. Chen CM, Fang CL, Chang CH. Surfactant and corticosteroid effects on lung function in a rat model of acute lung injury. Crit Care Med 2001;29:2169-75.
34. Cullen AB, Cox CA, Hipp SJ, Wolfson MR, Shaffer TH. Intratracheal delivery strategy of gentamicin with partial liquid ventilation. Respir Med 1999;93:770-8.
35. Mokra D, Mokry J, Drgova A, Petraskova M, Bulikova J, Calkovska A. Intratracheally administered corticosteroids improve lung function in meconium-instilled rabbits. J Physiol Pharmacol 2007;58:389-98. (Pubitemid 351346688)
36. Hvizdos KM, Jarvis B. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders. Drugs 2000;60:1141-78.
37. Szefler SJ. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid. J Allergy Clin Immunol 1999;104:175-83.
38. Arnon S. Grigg J, Nikander K, Silverman M. Delivery of micronized budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit. Pediatr Pulmonol 1992;13:172-5.
39. Plam S, Wiedmann TS. Note: dissolution of aerosol particles of budesonide in Survanta TM, a model lung surfactant. J Pharmaceutical Sci 2001;90:98-104. (Pubitemid 32050481)
40. Kharasch VS, Sweeney TD, Fredberg J, et al. Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am Rev Respir Dis 1991;144:909-13.
41. Yu ZW, Zhang JH. Effect of inhaled budesonide on surfactant protein expression in asthmatic mice. Allergy Asthma Proc 2008;29:486-92.
42. Bouwman AM, Heijstra MP, Schaefer NC, Duiverman EJ, Lesouëf PN, Devadason SG. Improved efficiency of budesonide nebulization using surface-active agents. Drug Deliv 2006;13:357-63.
43. Chen CM, Wang LF, Su B, Hsu HH. Methylprednisolone effects on oxygenation and histology in a rat model of acute lung injury. Pulm Pharmacol Ther 2003;16:215-20. (Pubitemid 36794387)
44. Chen CM, Su B, Hsu CC, Wang LF. Methylprednisolone does not enhance the surfactant effects on oxygenation and histology in paraquat-induced rat lung injury. Intensive Care Med 2002;28:1138-44. (Pubitemid 34985240)